摘要
目的:观察肠泰胶囊改善三硝基苯磺酸(TNBS)诱导的小鼠实验性结肠炎的作用及其初步的机制。方法:小鼠麻醉后直肠内灌注100μL含1.5mg TNBS的50%乙醇溶液制备结肠炎模型。造模后第2天开始给予肠泰胶囊,连续8d。观察小鼠的DAI评分、结肠组织学、结肠MPO活性、结肠黏膜糖原PAS染色及细胞因子IL-12/23 p40和IFN-γ的表达。结果:肠泰胶囊改善TNBS结肠炎小鼠的DAI评分(P<0.05),并能缓解结肠局部的炎症,改善结肠黏膜杯状细胞的分泌,减轻组织中炎性细胞的浸润,显著抑制结肠组织中IL-12/23 p40和IFN-γ的表达(P<0.01,P<0.05)。结论:肠泰胶囊对TNBS诱导的小鼠结肠炎具有明显的防治作用,其机制与抑制Th1反应有关。
Objective: To explore effects of Changtai Capsule on experimental colitis induced by trinitrobenzene sulfonic acid(TNBS) in mice. Methods: TNBS colitis was induced by 100μL rectal administration of 1.5 mg trinitrobenzene sulfonic acid in 50% ethanol. Changtai Capsule was administered on the 2 nd day after the establishment of the model for 8 consecutive days.Changes in disease activity index(DAI) together with histological scores were evaluated, and myeloperoxidase(MPO) in colonic tissue was detected, and Periodic Acid-Schiff(PAS) stain in colonic tissue was analyzed, and the production of IL-12/23 p40 and IFN-γ secreted in colonic tissue were determined with ELISA. Results: Changtai Capsule treatment significantly reduced DAI and histological scores of TNBS colitis in mice(P<0.05), it also alleviated neutrophil infiltration of colonic tissue in the model and improved the expression and secretion of goblet cells in colon mucosa. TNBS colitis mice have higher production of IL-12/23 p40 and IFNγ than that of control group, and Changtai Capsule suppress the secretion of IL-12/23 p40 and IFN-γ(P<0.01, P<0.05).Conclusion: Changtai Capsule has obvious preventive and therapeutic effects on TNBS-induced colitis in mice, and its mechanism is related to the inhibition of Th1 reaction.
引文
[1]杨佳,范恒.复方苦参汤对溃疡性结肠炎大鼠炎性反应和氧化应激的影响.中华中医药杂志,2017,32(8):3457-3461
[2]Kaser A,Zeissig S,Blumberg R.Inflammatory bowel disease.AnnuRev Immunol,2010,28:573-621
[3]戴萌,金雷,徐维田,等.TGF-β1中和抗体对TNBS慢性结肠炎动物模型纤维化的影响.世界华人消化杂志,2017,25(9):783-791
[4]张声生,沈洪,郑凯,等.溃疡性结肠炎中医诊疗专家共识意见(2017).中华中医药杂志,2017,32(8):3585-3589
[5]刘国山,施丽婕.溃疡性结肠炎在中医药领域中的文本挖掘.中医药学报,2017,45(4):40-43
[6]王爽,潘丹烨,甘爱萍.中医治疗溃疡性结肠炎研究概况.实用中医药杂志,2017,33(10):1225-1227
[7]Alex P,Zachos N C,Nguyen T,et al.Distinct cytokine patternsidentified from multiplex profiles of murine DSS and TNBS-induced colitis.Inflamm Bowel Dis,2009,15:341-352
[8]Rachmilewitz D,Karmeli F,Takabayashi K,et al.ImmunostimulatoryDNA ameliorates experimental and spontaneous murine colitis.Gastroenterology,2002,122:1428-1441
[9]Sujin Kang,Tatsusada Okuno,Noriko Takegahara,et al.IntestinalEpithelial Cell-derived Semaphorin 7A Negatively regulatesdevelopment of colitis viaαvβ1 integrin.The Journal ofImmunology,2012,188:1108-1116
[10]G Dothel,V Vasina,G Barbara,et al.Animal models of chemicallyinduced inflammation:Predictivity and ethical issues.Pharmacology&Therapeutics,2013,139:71-86
[11]徐连登,张宇霞,郑献敏.四神丸合四逆散治疗溃疡性结肠炎42例临床观察.吉林中医药,2012,32(5):483-484
[12]王玉珏.加味香连丸治疗溃疡性结肠炎63例.云南中医中药杂志,2010,31(4):86-87
[13]程虹,蒋巧俐,吴东方.青藤碱对TNBS诱导的慢性小鼠结肠炎的治疗作用.中国药师,2017,20(3):449-452
[14]陈东,王建民,李明,等.肠愈灌肠方对溃疡性结肠炎大鼠炎症相关因子及DOR、β-arrestin1、Bcl-2表达影响.中医药临床杂志,2017,29(1):90-94
[15]徐洋洋,蔡皓,段煜,等.白术芍药散治疗溃疡性结肠炎研究进展.中国中药杂志,2017,42(5):856-862
[16]Janek V,Kiyokazu K,Manjit B,et al.Reciprocal regulation ofsubstance P and IL-12/IL-23 and the associated cytokines, IFNγ/IL-17:A perspective on the relevance of this interaction to multipleSclerosis.Journal of Neuroimmune Pharmacology,2015,10:457-467
[17]P J Morrison,S J Ballantyne,M C Kullberg.Interleukin-23 and Thelper 17-type responses in intestinal inflammation:From cytokinesto T-cell plasticity.Immunology,2011,133:397-408
[18]Jacek T,Katarzyna P,Agnieszka K,et al.The Role of IL-17 and Th17Lymphocytes in Autoimmune Diseases.Archivum Immunologiae etTherapiae Experimentalis,2015,63:435-449